Capital Research Global Investors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.44B | Buy |
20,012,332
+7,968,909
| +66% | +$614M | 0.22% | 95 |
|
|
2025
Q4 | $956M | Buy |
12,043,423
+574,173
| +5% | +$45.3M | 0.18% | 108 |
|
|
2025
Q3 | $865M | Buy |
11,469,250
+2,253,531
| +24% | +$154M | 0.16% | 112 |
|
|
2025
Q2 | $636M | Sell |
9,215,719
-9,510,578
| -51% | -$624M | 0.13% | 132 |
|
|
2025
Q1 | $1.27B | Buy |
18,726,297
+16,220,891
| +647% | +$971M | 0.28% | 82 |
|
|
2024
Q4 | $112M | Sell |
2,505,406
-3,138,879
| -56% | -$176M | 0.02% | 289 |
|
|
2024
Q3 | $355M | Sell |
5,644,285
-29,811,224
| -84% | -$1.74B | 0.07% | 159 |
|
|
2024
Q2 | $2.09B | Buy |
35,455,509
+22,311,687
| +170% | +$1.4B | 0.46% | 53 |
|
|
2024
Q1 | $1.05B | Buy |
13,143,822
+184,297
| +1% | +$14.1M | 0.24% | 88 |
|
|
2023
Q4 | $1.02B | Sell |
12,959,525
-473,124
| -4% | -$33.7M | 0.25% | 89 |
|
|
2023
Q3 | $938M | Buy |
13,432,649
+7,795,109
| +138% | +$552M | 0.26% | 94 |
|
|
2023
Q2 | $390M | Buy |
+5,637,540
| New | +$401M | 0.1% | 164 |
|
|
2023
Q1 | – | Sell |
-2,562,112
| Closed | -$239M | – | 429 |
|
|
2022
Q4 | $239M | Sell |
2,562,112
-34,580
| -1% | -$3.34M | 0.07% | 198 |
|
|
2022
Q3 | $248M | Buy |
2,596,692
+1,446
| +0.1% | +$143K | 0.08% | 185 |
|
|
2022
Q2 | $240M | Buy |
2,595,246
+4,921
| +0.2% | +$480K | 0.07% | 195 |
|
|
2022
Q1 | $262M | Buy |
+2,590,325
| New | +$272M | 0.06% | 215 |
|
|
2019
Q2 | – | Sell |
-2,200,108
| Closed | -$119M | – | 408 |
|
|
2019
Q1 | $119M | Buy |
2,200,108
+13
| +0% | +$802 | 0.04% | 247 |
|
|
2018
Q4 | $144M | Hold |
2,200,095
| – | – | 0.05% | 229 |
|
|
2018
Q3 | $173M | Sell |
2,200,095
-2,326,628
| -51% | -$166M | 0.05% | 242 |
|
|
2018
Q2 | $291M | Buy |
4,526,723
+3,125
| +0.1% | +$206K | 0.08% | 200 |
|
|
2018
Q1 | $281M | Buy |
4,523,598
+12,461
| +0.3% | +$894K | 0.08% | 202 |
|
|
2017
Q4 | $327M | Buy |
4,511,137
+500,911
| +12% | +$36.4M | 0.1% | 177 |
|
|
2017
Q3 | $326M | Buy |
4,010,226
+500,996
| +14% | +$39.6M | 0.1% | 173 |
|
|
2017
Q2 | $282M | Sell |
3,509,230
-819,000
| -19% | -$64.7M | 0.09% | 188 |
|
|
2017
Q1 | $340M | Buy |
4,328,230
+3,509,230
| +428% | +$280M | 0.11% | 178 |
|
|
2016
Q4 | $64.6M | Buy |
+819,000
| New | +$66.3M | 0.02% | 314 |
|
|
2014
Q2 | – | Sell |
-13,446,652
| Closed | -$1.01B | – | 439 |
|
|
2014
Q1 | $1.01B | Hold |
13,446,652
| – | – | 0.36% | 79 |
|
|
2013
Q4 | $962M | Sell |
13,446,652
-4,527,222
| -25% | -$291M | 0.36% | 80 |
|
|
2013
Q3 | $1.02B | Hold |
17,973,874
| – | – | 0.4% | 68 |
|
|
2013
Q2 | $1.03B | Buy |
+17,973,874
| New | +$1.04B | 0.44% | 65 |
|
Other funds holding CVS
VCM
VPM
Capital Research Global Investors's CVS Position: Q1 2026 in Review
Capital Research Global Investors increased its CVS Health (CVS) stake by 66% in Q1 2026, buying an estimated $614M and bringing the position to 20,012,332 shares worth $1.44B. The position accounts for 0.22% of the portfolio, ranked #95.
Capital Research Global Investors first reported a position in CVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.09B in Q2 2024. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Capital Research Global Investors held 20,012,332 shares of CVS Health worth $1.44B as of Q1 2026.
- Capital Research Global Investors bought 7,968,909 CVS Health shares in Q1 2026, an estimated $614M.
- CVS Health made up 0.22% of Capital Research Global Investors's portfolio in Q1 2026, its #95 holding.
- Capital Research Global Investors first reported a position in CVS Health in Q2 2013 and has held it in 30 quarters since.
- Capital Research Global Investors's CVS Health position peaked at $2.09B in Q2 2024.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.